Stock Analysis

Tokio Marine Holdings Full Year 2024 Earnings: Beats Expectations

TSE:8766
Source: Shutterstock

Tokio Marine Holdings (TSE:8766) Full Year 2024 Results

Key Financial Results

  • Revenue: JP¥7.31t (up 10% from FY 2023).
  • Net income: JP¥695.8b (up 85% from FY 2023).
  • Profit margin: 9.5% (up from 5.7% in FY 2023). The increase in margin was driven by higher revenue.
  • EPS: JP¥352 (up from JP¥187 in FY 2023).
revenue-and-expenses-breakdown
TSE:8766 Revenue and Expenses Breakdown May 23rd 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Tokio Marine Holdings Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 5.8%. Earnings per share (EPS) also surpassed analyst estimates by 4.4%.

The primary driver behind last 12 months revenue was the International Insurance segment contributing a total revenue of JP¥3.65t (50% of total revenue). Notably, cost of sales worth JP¥5.03t amounted to 69% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to JP¥1.26t (79% of total expenses). Explore how 8766's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 1.1% growth forecast for the Insurance industry in Japan.

Performance of the Japanese Insurance industry.

The company's shares are up 5.2% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Tokio Marine Holdings' balance sheet and an in-depth analysis of the company's financial position.

Valuation is complex, but we're helping make it simple.

Find out whether Tokio Marine Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.